Zion Research has published a new report titled “Veterinary Vaccine Market by Application (Livestock Vaccines and Companion Vaccines), by Technology Types (Attenuated Vaccines, DNA Vaccines, Inactivated Vaccines, Toxoid Vaccines and Recombinant Vaccines) – Global Industry Perspective, Comprehensive Analysis and Forecast, 2015-2021”. According to the report, the global veterinary vaccines market accounted for around USD 12.10 billion in 2015 and is expected to reach approximately USD 20.60 billion by 2021, growing at a CAGR of around 9.3% between 2016 and 2021.
Get a copy of free Sample Report @ https://www.zionmarketresearch.com/sample/veterinary-vaccine-market
Vaccination is one of the mostly used applications of modern biotechnology to prevent chronic bacterial, viral and protozoal diseases. Veterinary vaccines are eco-friendly and used to increase animal welfare by preventing death of animals, loss of dairy products and monetary loss of owners. Recently highly effective third generation vaccine against rabies virus has been developed with the help of recombinant technology. With the use of vaccine we can avoid the problem of antibiotic and drug resistance by microorganism.
Major factors responsible for the growth of veterinary vaccines market include increasing pet ownership, increasing awareness for food security and increasing investment by various government agencies. Increased veterinary research institutions and colleges are also adding value to veterinary vaccines market. However, rising maintenance cost of vaccine storage and prevalence of chronic disease of animals with continuous economic slowdown are hindering the growth of market. Increasing demand for milk, eggs, meat & animal protein and investment by government would represent massive opportunity in future.
Know more before buying this report @ https://www.zionmarketresearch.com/inquiry/veterinary-vaccine-market
On the basis of product type the market of veterinary vaccines is bifurcated into livestock vaccines and companion vaccines. Livestock vaccines accounts larger market share of more than 62% and companion vaccines accounts for around 38% share of global veterinary vaccine market. Livestock vaccines segment is classified into poultry, porcine and aquaculture vaccine type. Porcine vaccine is largest sub segment with more than 30% share of global livestock market and it is expected to remain dominant during the forecast period. Companion vaccine is segmented into equine, canine and feline. Among these three segments canine segments is the fastest growing segment with approximately 6% growth rate.
On the basis of technology type the veterinary vaccines market is classified into attenuated vaccines, DNA Vaccines, inactivated vaccines, toxoid vaccines and recombinant vaccines. With noticeable share, DNA and attenuated vaccine segments were accounted highest growth for veterinary vaccine market in 2015.
The veterinary vaccine market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. As a result of increasing demand for livestock veterinary vaccines North America and Europe has strong hold on veterinary vaccine market with more than 68% share. In North America, the U.S. and Canada are two major markets, while the U.S. market is expected to remain dominant with nearly 38% share in forecast period due to increasing pet ownership and growing demand of dairy products. Asia Pacific is expected to show noticeable growth in forecast period as a result of strong demand from China and India.
Browse the full report at https://www.zionmarketresearch.com/report/veterinary-vaccine-market
Key operating players for veterinary vaccines market are Heska Corporation, Zoetis Inc., Ceva Santé Animale Inc., Merck Animal Health, Sanofi (Merial Animal Health), Boehringer Ingelheim GmbH, Eli Lilly and Company (Elanco Animal Health), Virbac, Bayer AG, and Bimeda.